arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Philip Morris International Inc

PM Health Care Medicinal Chemicals and Botanical Products
$182.53
▲ +0.0% Today
as of Sep 4, 16:53 ET
Last 30 days -8.02% Jul 29 → Sep 04
$181.26 $185.87 $190.49 $195.10 $199.71 Jul 29 Aug 05 Aug 13 Aug 20 Aug 28 Sep 04
Open
$185.03
High
$185.97
Low
$182.23
Volume
$3M
Avg Vol
$5M
Mkt Cap
$299.3B
P/E (TTM)
32.65
Beta
—
52w High
$207.76
52w Low
$142.11
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 1 ● 23 ▼ 1
Sep 1 · 16:55 Motley Fool neutral
I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.
Sep 1 · 12:15 PR Business Wire neutral
Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference
Sep 1 · 05:40 Barchart neutral
Philip Morris Stock: Is PM Outperforming the Consumer Staples Sector?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$142
$208
62% of range
Avg surprise (last 2)
+4.1%
Avg reaction (last 2)
-3.0%
50% positive
Latest IV / EM
46%
EM ±1.9% · $185 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.01$1.31$1.62$1.93$2.23 Actual $1.28Actual $1.01Actual $1.32Actual $1.38Actual $1.54Actual $1.97Actual $1.69Est $1.61Actual $1.91Est $1.85Actual $2.23Actual $1.56Actual $1.80 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$2.9B$5.9B$8.8B$11.8B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.80 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.56 — — — — financials
Tue Sep 30, 2025Sep 2025 $2.23 — — — — financials
Tue Jul 22, 2025Jun/2025 $1.91 $1.85 +3.2% — -8.4% earnings
Wed Apr 23, 2025Mar/2025 $1.69 $1.61 +5.0% — +2.4% earnings
Mon Sep 30, 2024Sep 2024 $1.97 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.54 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.32 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.01 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.28 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$11.19B$10.15B—$10.85B$10.14B$9.30B—$9.91B
Cost of revenue$3.53B$3.24B—$3.49B$3.27B$3.03B—$3.37B
Gross profit$7.66B$6.91B—$7.36B$6.87B$6.27B—$6.54B
Operating income$4.53B$3.89B—$4.26B$3.71B$3.54B—$3.65B
Net income$2.82B$2.44B—$3.48B$3.04B$2.69B—$3.08B
EPS (diluted)$1.80$1.56—$2.23$1.95$1.72—$1.97

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$6.00B$5.45B$4.87B$4.04B$4.14B$4.44B$4.22B$4.26B
Inventory$11.44B$11.39B$11.48B$10.27B$10.73B$10.13B$9.45B$9.36B
Total current assets$26.01B$25.60B$24.36B$22.66B$23.36B$22.20B$20.17B$20.80B
Total assets$68.27B$68.91B$69.19B$67.06B$68.51B$65.08B$61.78B$66.89B
Long-term debt————————
Total liabilities$74.93B$76.21B$77.21B$76.05B$78.52B$74.00B$71.65B$74.61B
Total equity$-8.58B$-7.30B$-9.99B$-10.91B$-10.01B$-8.93B$-11.75B$-7.71B

Implied volatility — last 90 days

27%39%51%63%76% Jun 07 — IV 34% · EM ±3.2%Jun 08 — IV 35% · EM ±2.9%Jun 09 — IV 33% · EM ±2.4%Jun 10 — IV 40% · EM ±2.3%Jun 11 — IV 44% · EM ±1.8%Jun 15 — IV 35% · EM ±2.5%Jun 16 — IV 37% · EM ±2.2%Jun 17 — IV 45% · EM ±1.9%Jun 19 — IV 34% · EM ±3.8%Jun 22 — IV 41% · EM ±3.4%Jun 23 — IV 34% · EM ±2.5%Jun 24 — IV 35% · EM ±2.1%Jun 25 — IV 43% · EM ±1.8%Jun 29 — IV 36% · EM ±7.5%Jun 30 — IV 37% · EM ±7.6%Jul 01 — IV 36% · EM ±7.3%Jul 02 — IV 37% · EM ±7.3%Jul 03 — IV 39% · EM ±7.5%Jul 06 — IV 39% · EM ±7.0%Jul 07 — IV 43% · EM ±7.4%Jul 08 — IV 41% · EM ±6.8%Jul 09 — IV 41% · EM ±6.6%Jul 10 — IV 41% · EM ±6.5%Jul 13 — IV 46% · EM ±6.3%Jul 14 — IV 49% · EM ±6.4%Jul 15 — IV 48% · EM ±6.0%Jul 16 — IV 50% · EM ±6.0%Jul 17 — IV 52% · EM ±5.7%Jul 20 — IV 65% · EM ±5.4%Jul 21 — IV 76% · EM ±5.5%Jul 22 — IV 43% · EM ±2.6%Jul 23 — IV 50% · EM ±2.1%Jul 27 — IV 34% · EM ±2.8%Jul 28 — IV 34% · EM ±2.5%Jul 29 — IV 42% · EM ±2.5%Jul 30 — IV 38% · EM ±1.6%Aug 03 — IV 35% · EM ±2.9%Aug 04 — IV 40% · EM ±2.9%Aug 05 — IV 40% · EM ±2.4%Aug 06 — IV 38% · EM ±1.6%Aug 10 — IV 29% · EM ±2.5%Aug 11 — IV 28% · EM ±2.1%Aug 12 — IV 29% · EM ±1.7%Aug 13 — IV 35% · EM ±1.4%Aug 17 — IV 29% · EM ±2.4%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 33% · EM ±1.9%Aug 20 — IV 49% · EM ±2.0%Aug 24 — IV 31% · EM ±2.5%Aug 25 — IV 27% · EM ±2.0%Aug 26 — IV 28% · EM ±1.7%Aug 27 — IV 35% · EM ±1.4%Aug 31 — IV 27% · EM ±2.3%Sep 01 — IV 28% · EM ±2.1%Sep 02 — IV 34% · EM ±2.0%Sep 03 — IV 46% · EM ±1.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
AZN
AstraZeneca PLC
$247.5B $161.47-0.8%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in